Granules India Limited (NSE: GRANULES)
India flag India · Delayed Price · Currency is INR
596.85
+10.15 (1.73%)
Dec 24, 2024, 3:30 PM IST

Granules India Company Description

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly.

The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors.

It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology.

Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Granules India Limited
Country India
Founded 1984
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 4,057

Contact Details

Address:
My Home Hub
Hyderabad, 500081
India
Phone 91 40 6904 3500
Website granulesindia.com

Stock Details

Ticker Symbol GRANULES
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE101D01020
SIC Code 2834

Key Executives

Name Position
Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D. Joint MD, Chief Executive Officer and Additional Director
Dr. Krishna Prasad Chigurupati B.Sc. Chairman and MD
Harsha Chigurupati BBA Executive Director
Sanjay Kumar President and Chief Strategy and Sustainability Officer
Mukesh Surana Chief Financial Officer
Sethu Madhavan Sankaran Senior Vice President of API Manufacturing and Operations
Dr. P. V. Srinivas Chief Technology Officer
Chaitanya Tummala Company Secretary and Compliance Officer
Atul Dhavle B.E. Chief Human Resources Officer
Priyanka Chigurupati Whole-Time Director